Ono Pharmaceutical Co. Ltd. (ON4)
Munich
Closed
Oct 8, 2026
Day's Range
12.7752 wk Range
9.60Overview - ON4 - Ono Pharmaceutical Co. Ltd.
Key Statistics
Valuation
Enterprise Value
-510.81M
P/E (Trailing)
‪16.37‬
PEG Ratio
‪-0.50‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪1.28‬
EV / EBITDA
‪-0.66‬
Profitability
Profit Margin
‪15.11%‬
Operating Margin
‪26.38%‬
Return on Assets
‪5.98%‬
Return on Equity
‪9.26%‬
Ownership
Shares Outstanding
469.90M
Float
453.49M
Held by Insiders
‪12.30%‬
Held by Institutions
‪40.65%‬
Price stats
Beta
‪0.13‬
50-Day Avg
‪13.15‬
200-Day Avg
‪12.92‬
Dividends
Payout Ratio
‪53.90%‬
Frequency
Semi-Annual
Market Cap - ON4 - Ono Pharmaceutical Co. Ltd.
Peers - ON4 - Ono Pharmaceutical Co. Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on Munich.
- ON4MunichOno Pharmaceutical Co. Ltd.6.31BMarket Cap+28.15%52-week change16.38P/E (Trailing)‪15.11%‬Profit Margin
- RHOAMunichRoche Holding AG290.82BMarket Cap-0.22%52-week change20.98P/E (Trailing)‪20.33%‬Profit Margin
- CUP0MunichChugai Pharmaceutical Co., Ltd.57.59BMarket Cap-18.86%52-week change21.88P/E (Trailing)‪35.10%‬Profit Margin
- SZD0MunichSanten Pharmaceutical Co., Ltd.3.08BMarket Cap+3.13%52-week change15.24P/E (Trailing)‪13.25%‬Profit Margin
Profile Summary - ON4 - Ono Pharmaceutical Co. Ltd.
About
Ono Pharmaceutical Co. Ltd. is a prominent player in the pharmaceuticals industry, engaged in the research, development, manufacture, and marketing of pharmaceutical products. The company focuses on developing innovative therapies to address unmet medical needs, concentrating its efforts on the fields of oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
